image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC2375059_pone-0002238-g012_22194.jpg | What is the central feature of this picture? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22204.jpg | What stands out most in this visual? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22209.jpg | What is the central feature of this picture? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22210.jpg | What key item or scene is captured in this photo? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22205.jpg | What's the most prominent thing you notice in this picture? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22212.jpg | What is being portrayed in this visual content? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22196.jpg | What is the dominant medical problem in this image? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22197.jpg | What is shown in this image? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22201.jpg | What is the central feature of this picture? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22208.jpg | What is the focal point of this photograph? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22202.jpg | What key item or scene is captured in this photo? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22206.jpg | What key item or scene is captured in this photo? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22199.jpg | Can you identify the primary element in this image? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22211.jpg | What object or scene is depicted here? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22195.jpg | What can you see in this picture? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375059_pone-0002238-g012_22203.jpg | What object or scene is depicted here? | Moesin and P-moesin expression and sub-cellular localization in human normal breast tissue, benign fibroadenomas and breast cancers.Histological sections (4 µm) from normal mammary glands, fibroadenomas or ER positive (ER+) breast cancers were used to identify the expression and localization of moesin and P-moesin with... |
PMC2375112_pone-0002240-g001_22218.jpg | Describe the main subject of this image. | The thylacine, Thylacinus cynocephalus.
(a) Young male thylacine in Hobart Zoo in 1928, photograph (Q4437). (b) One of the preserved pouch young specimens (head length 34 mm) from which DNA was extracted, from the Museum Victoria collection. (c-f) The skull of the thylacine (c,e) compared with that of the domestic dog ... |
PMC2375112_pone-0002240-g001_22216.jpg | What does this image primarily show? | The thylacine, Thylacinus cynocephalus.
(a) Young male thylacine in Hobart Zoo in 1928, photograph (Q4437). (b) One of the preserved pouch young specimens (head length 34 mm) from which DNA was extracted, from the Museum Victoria collection. (c-f) The skull of the thylacine (c,e) compared with that of the domestic dog ... |
PMC2375112_pone-0002240-g001_22214.jpg | What key item or scene is captured in this photo? | The thylacine, Thylacinus cynocephalus.
(a) Young male thylacine in Hobart Zoo in 1928, photograph (Q4437). (b) One of the preserved pouch young specimens (head length 34 mm) from which DNA was extracted, from the Museum Victoria collection. (c-f) The skull of the thylacine (c,e) compared with that of the domestic dog ... |
PMC2375112_pone-0002240-g001_22217.jpg | What is the principal component of this image? | The thylacine, Thylacinus cynocephalus.
(a) Young male thylacine in Hobart Zoo in 1928, photograph (Q4437). (b) One of the preserved pouch young specimens (head length 34 mm) from which DNA was extracted, from the Museum Victoria collection. (c-f) The skull of the thylacine (c,e) compared with that of the domestic dog ... |
PMC2375113_pone-0002252-g003_22221.jpg | What object or scene is depicted here? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22227.jpg | What is shown in this image? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22222.jpg | What's the most prominent thing you notice in this picture? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22226.jpg | What is the central feature of this picture? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22224.jpg | What does this image primarily show? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22228.jpg | What is the focal point of this photograph? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22223.jpg | What is the central feature of this picture? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375113_pone-0002252-g003_22225.jpg | What is the central feature of this picture? | Engraftment of hE in NODscid/β2m−/−.(A) Long term kinetics of engraftment of NODscid β2m−/− mice with hE. Data are the mean percentage±SE of hE (TER-119− or human glycophorin-A+ mouse) erythrocytes pooled from 142 mice. The inset plot shows the effect of human serum deprivation from daily-inoculated hE on engraftment o... |
PMC2375116_pgen-1000079-g002_22231.jpg | What is the main focus of this visual representation? | Methylated histone H3 marks exhibit a non-random subnuclear distribution.(A) Dual immunofluorescence confocal analysis of domains enriched in H3-Lys4me2, H3-Lys9me3, and H3-Lys27me3 (red) compared with RNA polymerase II (green) in interphase wild-type hepatocyte nuclei. Adjacent Venn diagrams display percentages of col... |
PMC2375116_pgen-1000079-g002_22232.jpg | What is being portrayed in this visual content? | Methylated histone H3 marks exhibit a non-random subnuclear distribution.(A) Dual immunofluorescence confocal analysis of domains enriched in H3-Lys4me2, H3-Lys9me3, and H3-Lys27me3 (red) compared with RNA polymerase II (green) in interphase wild-type hepatocyte nuclei. Adjacent Venn diagrams display percentages of col... |
PMC2375125_F6_22243.jpg | What is being portrayed in this visual content? | Top 10 results for a set of spatial homology searches are shown overlaid for subregions of the hippocampus. The seeds used are shown in Figure 5: Prox1 for the dentate gyrus (a), Ptpru for CA1 (b), Cacng5 for CA2 (c), Prss35 for CA3 (d) and Cd44 for the ventral CA3 (e). The view is restricted to the hippocampal region.... |
PMC2375125_F6_22242.jpg | What can you see in this picture? | Top 10 results for a set of spatial homology searches are shown overlaid for subregions of the hippocampus. The seeds used are shown in Figure 5: Prox1 for the dentate gyrus (a), Ptpru for CA1 (b), Cacng5 for CA2 (c), Prss35 for CA3 (d) and Cd44 for the ventral CA3 (e). The view is restricted to the hippocampal region.... |
PMC2375172_fig4_22269.jpg | What is being portrayed in this visual content? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22264.jpg | What key item or scene is captured in this photo? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22266.jpg | What is the focal point of this photograph? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22265.jpg | Describe the main subject of this image. | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22271.jpg | What is shown in this image? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22272.jpg | What is the dominant medical problem in this image? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22270.jpg | What can you see in this picture? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22267.jpg | What's the most prominent thing you notice in this picture? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22255.jpg | What is the core subject represented in this visual? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22263.jpg | What stands out most in this visual? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22252.jpg | What key item or scene is captured in this photo? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22254.jpg | What object or scene is depicted here? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22260.jpg | What is the main focus of this visual representation? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22268.jpg | What can you see in this picture? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22257.jpg | What is being portrayed in this visual content? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22258.jpg | What is shown in this image? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig4_22259.jpg | What's the most prominent thing you notice in this picture? | Expression of G30CC in human squamous cell cervical carcinoma of different FIGO stages (1B, 2A, 2B and 3B), as well as their corresponding adjacent normal via RNA–RNA in situ hybridization analysis. The RNA–RNA in situ hybridization was performed by DIG-labelled cRNA probe using the DIG RNA labelling Kit from Boehringe... |
PMC2375172_fig5_22244.jpg | What is the focal point of this photograph? | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375172_fig5_22251.jpg | Describe the main subject of this image. | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375172_fig5_22250.jpg | What is shown in this image? | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375172_fig5_22245.jpg | What is the principal component of this image? | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375172_fig5_22247.jpg | What is shown in this image? | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375172_fig5_22249.jpg | What is the dominant medical problem in this image? | Expression of G30CC in normal epithelium of tissue biopsies obtained from four different non-cervical cancer patients via RNA–RNA in situ hybridization analysis. Sub-clones with the G30CC gene fragment inserted in opposite orientation were selected for the synthesis of the sense and anti-sense hybridization probes. The... |
PMC2375178_fig2_22274.jpg | What is the dominant medical problem in this image? | Immunohistochemical preparations of adjacent sections of a D-12 tumour. An avidin-biotin peroxidase-based method was used for staining. Haematoxylin was used for counterstaining. IL-8 positive foci visualized by anti-IL-8 antibody staining (A) and hypoxic foci visualized by anti-pimonidazole antibody staining (B). |
PMC2375178_fig2_22273.jpg | What is the core subject represented in this visual? | Immunohistochemical preparations of adjacent sections of a D-12 tumour. An avidin-biotin peroxidase-based method was used for staining. Haematoxylin was used for counterstaining. IL-8 positive foci visualized by anti-IL-8 antibody staining (A) and hypoxic foci visualized by anti-pimonidazole antibody staining (B). |
PMC2375208_fig1_22278.jpg | What is the focal point of this photograph? | Pre- and post-treatment CT scan of responding patient. |
PMC2375213_fig4_22291.jpg | What is shown in this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22287.jpg | What stands out most in this visual? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22293.jpg | What is the principal component of this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22295.jpg | What is the principal component of this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22292.jpg | Describe the main subject of this image. | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22288.jpg | What is the dominant medical problem in this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22297.jpg | What is the principal component of this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22294.jpg | Can you identify the primary element in this image? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig4_22296.jpg | What is the core subject represented in this visual? | Tumour angiogenesis observation in transparent skin chamber after implantation of 2×105 Panc-1 wild-type (upper panels), Panc-1/BAI1 (middle panels), or Panc-1/LacZ (lower panels) cells at day 0 (A,E,I), day 3 (B,F,J), day 7 (C,G,K) and day 14 (D,H,L). BAI1 transfected tumour cells failed to promote angiogenesis after ... |
PMC2375213_fig5_22282.jpg | What is the dominant medical problem in this image? | H&E staining of sections from Panc-1 (A), Panc-1/BAI11 (B), and Panc-1/LacZ 1 (C) tumours (magnification, ×10). Large areas of necrosis in the Panc-1/BAI1 tumour samples. Also, the expression of the endothelial cell marker CD31 in human Panc-1 (D), Panc-1/BAI11 (E), and Panc-1/LacZ (F) tumours from immunodeficient mice... |
PMC2375213_fig5_22283.jpg | What is being portrayed in this visual content? | H&E staining of sections from Panc-1 (A), Panc-1/BAI11 (B), and Panc-1/LacZ 1 (C) tumours (magnification, ×10). Large areas of necrosis in the Panc-1/BAI1 tumour samples. Also, the expression of the endothelial cell marker CD31 in human Panc-1 (D), Panc-1/BAI11 (E), and Panc-1/LacZ (F) tumours from immunodeficient mice... |
PMC2375213_fig5_22279.jpg | What is the dominant medical problem in this image? | H&E staining of sections from Panc-1 (A), Panc-1/BAI11 (B), and Panc-1/LacZ 1 (C) tumours (magnification, ×10). Large areas of necrosis in the Panc-1/BAI1 tumour samples. Also, the expression of the endothelial cell marker CD31 in human Panc-1 (D), Panc-1/BAI11 (E), and Panc-1/LacZ (F) tumours from immunodeficient mice... |
PMC2375213_fig5_22281.jpg | What key item or scene is captured in this photo? | H&E staining of sections from Panc-1 (A), Panc-1/BAI11 (B), and Panc-1/LacZ 1 (C) tumours (magnification, ×10). Large areas of necrosis in the Panc-1/BAI1 tumour samples. Also, the expression of the endothelial cell marker CD31 in human Panc-1 (D), Panc-1/BAI11 (E), and Panc-1/LacZ (F) tumours from immunodeficient mice... |
PMC2375278_fig3_22300.jpg | What stands out most in this visual? | (a) 69-year-old patient with histopathologically proven HCC in segment 5/8. Pretreatment CT scan on the left side, lesion identified with decreased attenuation values. CT scan 2 weeks after the fourth/last treatment with IntraDose® gel. Segment 5/8 reveals an irregular area of necrosis that developed after treatment (a... |
PMC2375278_fig3_22299.jpg | What stands out most in this visual? | (a) 69-year-old patient with histopathologically proven HCC in segment 5/8. Pretreatment CT scan on the left side, lesion identified with decreased attenuation values. CT scan 2 weeks after the fourth/last treatment with IntraDose® gel. Segment 5/8 reveals an irregular area of necrosis that developed after treatment (a... |
PMC2375278_fig3_22298.jpg | What is shown in this image? | (a) 69-year-old patient with histopathologically proven HCC in segment 5/8. Pretreatment CT scan on the left side, lesion identified with decreased attenuation values. CT scan 2 weeks after the fourth/last treatment with IntraDose® gel. Segment 5/8 reveals an irregular area of necrosis that developed after treatment (a... |
PMC2375278_fig4_22301.jpg | What can you see in this picture? | A 55-year-old patient with colorectal metastases to the liver. (a) Pretreatment CT scan in segment 8 (portal venous phase). (b) CT scan (portal venous phase) at 8 weeks after the pretreatment evaluation and 2 weeks after the fourth treatment. Increased tumour necrosis is evident after treatment. |
PMC2375278_fig4_22302.jpg | Describe the main subject of this image. | A 55-year-old patient with colorectal metastases to the liver. (a) Pretreatment CT scan in segment 8 (portal venous phase). (b) CT scan (portal venous phase) at 8 weeks after the pretreatment evaluation and 2 weeks after the fourth treatment. Increased tumour necrosis is evident after treatment. |
PMC2375288_fig3_22304.jpg | What is shown in this image? | Ang1 overexpression causes marked infiltration of smooth muscle cells into tumours. (a) Microscopic image of a section of control MCF-7 tumours. (b) Microscopic image of a section of Ang1-overexpressing tumours. Tumour sections were immunostained for smooth muscle cells with antibody to α-smooth muscle actin and DAB su... |
PMC2375322_fig7_22307.jpg | What stands out most in this visual? | Histological sections of C6 tumours stained with Haematoxylin-Eosin and light green. C6 tumours from TR-treated animals are different from C6 tumours from control non-treated animals. Cells in tumours from control non-treated animals have a more pleomorphic appearance, with a bizarre form. Cell size and shape in tumour... |
PMC2375322_fig7_22306.jpg | What stands out most in this visual? | Histological sections of C6 tumours stained with Haematoxylin-Eosin and light green. C6 tumours from TR-treated animals are different from C6 tumours from control non-treated animals. Cells in tumours from control non-treated animals have a more pleomorphic appearance, with a bizarre form. Cell size and shape in tumour... |
PMC2375337_fig1_22311.jpg | What can you see in this picture? | Immunohistochemical detection of MCT1 in healthy human colon. Immunohistochemistry for MCT1 and villin was carried out on healthy human colon biopsy sections using a peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen as a brown colouring contrasting with th... |
PMC2375337_fig2_22320.jpg | What is the focal point of this photograph? | Detection of MCT1 mRNA in healthy human colonic biopsy sections by in situ hybridisation. In situ hybridisation was carried out on healthy human colon biopsy sections using DIG labelled cRNA probes as described in the Materials and Methods section. Sections were hybridised with a specific antisense probe for MCT1 and t... |
PMC2375337_fig2_22318.jpg | What's the most prominent thing you notice in this picture? | Detection of MCT1 mRNA in healthy human colonic biopsy sections by in situ hybridisation. In situ hybridisation was carried out on healthy human colon biopsy sections using DIG labelled cRNA probes as described in the Materials and Methods section. Sections were hybridised with a specific antisense probe for MCT1 and t... |
PMC2375337_fig2_22321.jpg | What is the core subject represented in this visual? | Detection of MCT1 mRNA in healthy human colonic biopsy sections by in situ hybridisation. In situ hybridisation was carried out on healthy human colon biopsy sections using DIG labelled cRNA probes as described in the Materials and Methods section. Sections were hybridised with a specific antisense probe for MCT1 and t... |
PMC2375337_fig3_22314.jpg | What can you see in this picture? | Immunohistochemical detection of MCT1 in normal, adenoma and carcinoma human colonic sections. Immunohistochemistry was carried out on normal, adenoma and carcinoma human colonic tissue using a horseradish peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen ... |
PMC2375337_fig3_22317.jpg | What is the core subject represented in this visual? | Immunohistochemical detection of MCT1 in normal, adenoma and carcinoma human colonic sections. Immunohistochemistry was carried out on normal, adenoma and carcinoma human colonic tissue using a horseradish peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen ... |
PMC2375337_fig3_22312.jpg | What key item or scene is captured in this photo? | Immunohistochemical detection of MCT1 in normal, adenoma and carcinoma human colonic sections. Immunohistochemistry was carried out on normal, adenoma and carcinoma human colonic tissue using a horseradish peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen ... |
PMC2375337_fig3_22316.jpg | What object or scene is depicted here? | Immunohistochemical detection of MCT1 in normal, adenoma and carcinoma human colonic sections. Immunohistochemistry was carried out on normal, adenoma and carcinoma human colonic tissue using a horseradish peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen ... |
PMC2375337_fig3_22315.jpg | What object or scene is depicted here? | Immunohistochemical detection of MCT1 in normal, adenoma and carcinoma human colonic sections. Immunohistochemistry was carried out on normal, adenoma and carcinoma human colonic tissue using a horseradish peroxidase-conjugated secondary antibody as described in the Materials and Methods section. MCT1 staining is seen ... |
PMC2375347_fig1_22323.jpg | What is the main focus of this visual representation? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig1_22322.jpg | What stands out most in this visual? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig1_22324.jpg | What is the dominant medical problem in this image? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig1_22327.jpg | What is the main focus of this visual representation? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig1_22325.jpg | What stands out most in this visual? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig1_22326.jpg | What is the principal component of this image? | Expression of PPARγ protein of the cells in grade I (A,B) and grade II (C,D) areas within chondrosarcoma specimens from patients. Note there are few positive immuno-reactions in the cells in the grade III areas (E,F). Magnification; A,C,E 50×, B,D,F 100×. |
PMC2375347_fig5_22330.jpg | What is the principal component of this image? | Cell morphology after incubation with or without 15d-PGJ2. The cells were treated by 10 μg ml−2 of 15d-PGJ2 for 8 h, and the cell pellet was embedded in hydrophilic resin. Semi-thin sections stained by toluidine blue show cell shrinkage and nuclear condensation (arrow heads) (B). TEM analysis of ultra-thin section afte... |
PMC2375347_fig5_22329.jpg | What does this image primarily show? | Cell morphology after incubation with or without 15d-PGJ2. The cells were treated by 10 μg ml−2 of 15d-PGJ2 for 8 h, and the cell pellet was embedded in hydrophilic resin. Semi-thin sections stained by toluidine blue show cell shrinkage and nuclear condensation (arrow heads) (B). TEM analysis of ultra-thin section afte... |
PMC2375347_fig5_22328.jpg | What can you see in this picture? | Cell morphology after incubation with or without 15d-PGJ2. The cells were treated by 10 μg ml−2 of 15d-PGJ2 for 8 h, and the cell pellet was embedded in hydrophilic resin. Semi-thin sections stained by toluidine blue show cell shrinkage and nuclear condensation (arrow heads) (B). TEM analysis of ultra-thin section afte... |
PMC2375354_fig1_22332.jpg | What is the central feature of this picture? | Immunofluorescence analysis of MDM2 and P14ARF expression in two cases of liver cirrhosis using confocal laser scanning microscopy. Different areas from regenerative nodules are presented containing hepatocytes overexpressing the proteins (bar: 10 μm). The upper row contains the images in confocal fluorescence. In the ... |
PMC2375354_fig1_22334.jpg | Can you identify the primary element in this image? | Immunofluorescence analysis of MDM2 and P14ARF expression in two cases of liver cirrhosis using confocal laser scanning microscopy. Different areas from regenerative nodules are presented containing hepatocytes overexpressing the proteins (bar: 10 μm). The upper row contains the images in confocal fluorescence. In the ... |
PMC2375354_fig1_22333.jpg | What does this image primarily show? | Immunofluorescence analysis of MDM2 and P14ARF expression in two cases of liver cirrhosis using confocal laser scanning microscopy. Different areas from regenerative nodules are presented containing hepatocytes overexpressing the proteins (bar: 10 μm). The upper row contains the images in confocal fluorescence. In the ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.